In 2018, Gong et al. [102] identified circ-ZEB1.33 being significantly higher in serum of HCC patients compared to healthy controls, and its levels were positively correlated with the increase of TMN stage, being higher in the III–IV stage compared to the I–II stage. The gene discussed is ZEB1; the disease is hepatocellular carcinoma.